Market Overview

B. Riley FBR Initiates Coverage On Rexahn Pharmaceuticals, Inc. Common Stock with Buy Rating, Announces $7.50 Price Target


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for RNN

Jul 2018B. Riley FBRInitiates Coverage OnBuy
Oct 2017Seaport GlobalInitiates Coverage OnBuy
Apr 2017Rodman & RenshawInitiates Coverage OnBuy

View More Analyst Ratings for RNN
View the Latest Analyst Ratings

Posted-In: News Initiation Analyst Ratings


Related Articles (RNN)

Zagg Q2 Earnings Preview

Earnings Preview: Genworth Financial